The Timing and Extent of Androgen Deprivation Therapy for Prostate Cancer: Weighing the Clinical Evidence-Reference-Cited by-同舟云学术

The Timing and Extent of Androgen Deprivation Therapy for Prostate Cancer: Weighing the Clinical Evidence

Published:2011-09 Issue:3 Volume:40 Page:615-623
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Ginzburg Serge,Albertsen Peter C.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference47 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

2. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry;Cooperberg;J Urol,2004

3. Studies on prostatic cancer II: the effects of castration on advanced carcinoma of the prostate gland;Huggins;Arch Surg,1941

4. Proceedings: the Veterans Administration Cooperative Urological Research Group’s studies of cancer of the prostate;Byar;Cancer,1973

5. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group;Surg Gynecol Obstet,1967

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma;IUBMB Life;2014-12

2. Will new AR inhibitors reshape the prostate cancer landscape?;The Lancet Oncology;2014-08

3. Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist;European Urology;2014-03

4. Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells;International Journal of Oncology;2012-11-06